Jacobs Levy Equity Management
TECX

Jacobs Levy Equity Management’s Tectonic Therapeutic TECX Stock Holding History

Jacobs Levy Equity Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,121
Closed -$514K – 1096
2021
Q4 		$514K Sell
11,121
-12,232
-52% -$703K ﹤0.01% 831
2021
Q3 		$1.56M Sell
23,353
-5,221
-18% -$428K 0.01% 665
2021
Q2 		$3.05M Sell
28,574
-71
-0.2% -$8.42K 0.02% 531
2021
Q1 		$4.36M Buy
28,645
+23,579
+465% +$3.84M 0.03% 444
2020
Q4 		$847K Buy
+5,066
New +$901K 0.01% 758

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management's TECX Position: Q1 2022 in Review

Jacobs Levy Equity Management sold out of Tectonic Therapeutic (TECX) in Q1 2022, closing a stake of 11,121 shares — an estimated $514K sold.

Jacobs Levy Equity Management first reported a position in TECX in Q4 2020 and held it in 5 quarters. The position peaked at $4.36M in Q1 2021. 79 funds tracked by Wall St. Rank hold TECX as of Q1 2022.

  • Jacobs Levy Equity Management reported no remaining Tectonic Therapeutic position as of Q1 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 11,121 Tectonic Therapeutic shares in Q1 2022, an estimated $514K.
  • Jacobs Levy Equity Management first reported a position in Tectonic Therapeutic in Q4 2020 and held it in 5 quarters.
  • Jacobs Levy Equity Management's Tectonic Therapeutic position peaked at $4.36M in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2022, filed 16 May 2022.